These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20606531)

  • 1. Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy.
    Mabuchi S; Isohashi F; Yoshioka Y; Temma K; Takeda T; Yamamoto T; Enomoto T; Morishige K; Inoue T; Kimura T
    Int J Gynecol Cancer; 2010 Jul; 20(5):834-40. PubMed ID: 20606531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
    Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Analysis of Surgery for Recurrent Cervical Cancer: A Review of 45 Cases].
    Han Y; Wu LY; Li N; Li XG; Zhang R; Sun YC
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):369-373. PubMed ID: 28535655
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients.
    Matsumoto Y; Mabuchi S; Isohashi F; Komura N; Ogawa K; Kimura T
    Int J Clin Oncol; 2020 Jun; 25(6):1170-1177. PubMed ID: 32152766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?
    Yuce Sari S; Guler OC; Gultekin M; Onal HC; Yildiz F
    Oncol Res Treat; 2017; 40(9):523-527. PubMed ID: 28848218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer.
    Mabuchi S; Matsumoto Y; Hamasaki T; Kawano M; Hisamatsu T; Mutch DG; Kimura T
    Int J Gynecol Cancer; 2012 Nov; 22(9):1545-51. PubMed ID: 23051956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent cervical cancer: detection and prognosis.
    Duyn A; Van Eijkeren M; Kenter G; Zwinderman K; Ansink A
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):759-63. PubMed ID: 12174162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
    Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of anemia for patients with cervical cancer treated with irradiation].
    Grigiene R; Aleknavicius E; Kurtinaitis J
    Medicina (Kaunas); 2005; 41(11):916-24. PubMed ID: 16333214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women.
    Park JH; Kim YS; Ahn SD; Choi EK; Shin SS; Kim YT; Kim YM; Kim JH; Yi SY; Nam JH
    Tumori; 2010; 96(6):959-65. PubMed ID: 21388059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.